Which hedge funds own CNMD? CONMED CORP, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in CNMD (CONMED CORP) in their Q2 2026 13F filings, worth $20.2m in total. The largest holder by portfolio weight is Moore Capital Management at 0.0% of its book. 1 manager opened a new position this quarter: Tudor Investment. 1 exited: Brevan Howard Capital Management.
7tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold CNMD? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.0% | $825.8k | 25,230 | 3% | added |
| Marshall Wace | Q2 2026 | 0.0% | $5.7m | 175,454 | 3% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $2.3m | 69,585 | -48% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $762.7k | 23,303 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $4.7m | 142,263 | -42% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $3.8m | 114,609 | 51% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.2m | 68,134 | 42% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $1.7m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.0% |
How has hedge fund ownership of CNMD changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $20.2m |
| Q1 2026 | 7 | $26.4m |
| Q4 2025 | 5 | $10.1m |
| Q3 2025 | 4 | $9.1m |
| Q2 2025 | 4 | $72.7m |
| Q1 2025 | 1 | $1.9m |
| Q4 2024 | 1 | $218.8k |
| Q3 2024 | 3 | $9.3m |
| Q2 2024 | 2 | $7.7m |
| Q1 2024 | 3 | $11.6m |
| Q4 2023 | 3 | $20.9m |
| Q3 2023 | 2 | $8.2m |
| Q2 2023 | 2 | $2.6m |
| Q1 2023 | 3 | $12.7m |
| Q4 2022 | 3 | $9.7m |
| Q3 2022 | 4 | $9.0m |
Counts every tracked manager that disclosed CNMD in that quarter's filing, including managers that have since stopped filing.